ENMD-1068 | m-entrepreneurship.com

Product Name :
ENMD-1068

Search keywords :
ENMD-1068

drugId :
null

Target Vo:
Protease-activated receptor-2

Target Vo Short Name :
PAR-2

Moa_Name:
Protease-activated receptor-2 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Casi Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
EIF2A Rabbit mAb custom synthesis
Bcl-XL Rabbit mAb custom synthesis
DNMT1 Antibody (YA781): DNMT1 Antibody (YA781) is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to DNMT1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts